Last Price Today's Change   Day's Range   Trading Volume
0.011   0.00 (0.00%)  0.011 - 0.011  0


Avg Volume (4 weeks):0
4 Weeks Range:0.011 - 0.011
4 Weeks Price Volatility (%):
52 Weeks Range:0.008 - 0.023
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Alchemia Limited is a biotechnology company. The Company is engaged in the sale of its around the world intellectual property rights to Fondaparinum sodium, a generic anti-coagulant drug to Dr Reddy's Laboratories; closure of clinical trial activities, and review of new opportunities. The Company's segments include Fondaparinux and HyACT. The Company is engaged in the commercialization and improvements of its generic Fondaparinux product. The Company's HyACT is a platform technology that targets cancer drugs directly to tumors, designed to increase effectiveness against tumors without increasing toxicity. Its lead product candidate, HA-Irinotecan is used in the treatment of metastatic colorectal cancer (mCRC) and is in Phase III clinical trials. Its subsidiary, Alchemia Oncology Inc. is engaged in commercializing its HyACT and VAST platforms, including HA-Irinotecan. The Company's Audeo Oncology, Inc is engaged in the development and commercialization of the HyACT platform.

  Be the first to like this.


555  649  673  9296 

Top 10 Active Counters
 ANL 0.0030.00 
 CTM 0.011+0.002 
 AMP 1.735-0.09 
 MSE 0.019+0.008 
 TLS 3.77-0.10 
 BLK 0.0140.00 
 SWM 0.40+0.025 
 MEI 0.039+0.003 
 CWY 2.11+0.06 
 LNY 0.0090.00 
Partners & Brokers